Skip to content
OpenCapital
Get started

Danaher DHR Diagnostics — Depreciation

Similar metrics at other companies

Labcorp Holdings logo
LHDiagnostics — Depreciation
$63.8M+3.4%
Revvity logo
RVTYDiagnostics — Depreciation
$9.56M+39.6%
Bio-Rad Laboratories logo
BIOClinical Diagnostics — Depreciation, Depletion and Amortization
$22.6M+7.1%
Opko Health logo
OPKDiagnostics — D&A
$3.88M-20.5%
Abbott logo
ABTDiagnostic Products — Depreciation
$165M+22.2%
Opko Health logo
OPKDiagnostics — Intangible Amortization
$2.53M-16.4%

Other financials

Income statement

See full
Revenue$6.3B+5.5%
Gross profit$3.6B+2.5%
Operating income$1.1B+48.3%
Net income$870.0M+56.8%
EPS (diluted)$1.23+59.7%

Balance sheet

See full
Cash & equivalents$4.3B+47.0%
Total debt$27.9B+50.1%
Total equity$52.6B+0.5%
Total assets$92.4B+13.2%

Cash flow

See full
Operating cash flow$1.5B+14.6%
CapEx$269.0M+8.5%
Free cash flow$1.3B+16.1%

Valuation

See full
Market cap$134.62B-7.4%
Enterprise value$158.13B-1.7%
P/E33.6×-9.0×
P/S5.4×-0.7×

Profitability

See full
Gross margin58.5%-1.1pp
Operating margin20.4%+2.0pp
Net margin15.9%+1.7pp
FCF margin21.8%+1.5pp

Returns & leverage

See full
Return on equity7.6%+1.0pp
Debt / equity0.5×+0.2×
Current ratio1.7×0.0×

Where this comes from

Reported directly by Danaher in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: Danaher’s 10-Q, filed July 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about Danaher's diagnostics — depreciation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Danaher's diagnostics — depreciation?
Danaher (DHR) reported diagnostics — depreciation of $107M in Q2 2026.
How has Danaher's diagnostics — depreciation changed year-over-year?
Danaher's diagnostics — depreciation increased by 7.0% year-over-year, from $100M to $107M.
What is the long-term trend for Danaher's diagnostics — depreciation?
Over 2 years (2023 to 2025), Danaher's diagnostics — depreciation has grown at a 3.6% compound annual growth rate (CAGR), from $379M to $407M.
What does diagnostics — depreciation mean?
The systematic allocation of the cost of tangible fixed assets, such as manufacturing equipment and laboratory facilities, over their useful lives. This non-cash expense reflects the wear and tear of assets used to produce diagnostic goods. It is a key component in calculating the segment's true operational cash flow.